Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Compliance Certificate Pursuant To Regulation 7(3) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Pursuant to Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we certify that M/s Alankit Assignments Limited, a Category-I Registrar and Share Transfer Agent, registered with the Securities and Exchange Board of India vide Registration No.: INR000002532, is the Registrar and Share Transfer Agent (the 'RTA') of Jubilant Life Sciences Limited (the 'Company') and all activities in relation to both physical and electronic share transfer facility of the Company are being maintained by the RTA.
15-04-2019
Bigul

Jubilant Life Sciences arm recalls 12,960 bottles of esophagitis drug in US

 Reason for recall is "Discoloration: expansion of an earlier recall due to the presence of dark brown discoloration on the edges of the tablets"
14-04-2019
Bigul

Jubilant Life Sciences Ltd - 530019 - Undertaking Under Regulation 57(2) Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations, 2015

 Dear Sirs, We wish to inform you that the Company has provided all the documents and intimations required to be submitted to the Debenture Trustee i.e. Vistra ITCL (India) Limited during the Financial Year 2018-19 in terms of the Debenture Trust Deeds and the SEBI (Issue and Listing of Debt Securities) Regulations, 2008. This is for your information and records.
08-04-2019
Bigul

Jubilant Life Sciences settles IFC loan with $135-mn payout

 Drug firm Jubilant Life Sciences on Friday said its subsidiary has redeemed the outstanding loan of Washington-based International Finance Corporatio
29-03-2019
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015

 Sub: Intimation under the SEBI (Prohibition of Insider Trading) Regulations, 2015 With reference to the captioned subject, we wish to inform the following: 1. The Board of Directors of the Company has, at its meeting held on Friday, March 29, 2019, approved revision in the Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information. The said code has been published on the website of the Company. 2. The Board of Directors of the Company has also approved revision in the Code of Conduct for Prevention of Insider Trading. This is for your information and records.
29-03-2019
Bigul

Jubilant Life Sciences Ltd - 530019 - Jubilant And IFC Mutually Agree For Settlement Of Zero Coupon Convertible Loan

 Dear Sirs, We enclose a communication pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This is for your information and records.
29-03-2019
Bigul

Jubilant Life Sciences hits four-month low; falls 21% in five days

 The stock slipped 5 per cent to Rs 689. It was trading at its lowest level since November 21, 2018.
26-03-2019
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Closure of Trading Window

 Sub: Intimation regarding closure of Trading Window Pursuant to the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company will be closed for 'Designated Persons' from Monday, March 25, 2019 and the same shall remain closed till 48 hours after announcement of the financial results for the quarter and year ending March 31, 2019 to the Stock Exchanges. Accordingly, the Designated Persons have been intimated not to trade in the securities of the Company during the aforesaid period of closure of Trading Window. This is for your information and records.
22-03-2019
Bigul

JUBILANT LIFE SCIENCES LIMITED - 530019 - Clarification

 With reference to increase in Volume, Jubilant Life Sciences Ltd has submitted to BSE a copy of Clarification is enclosed.
22-03-2019
Bigul

Jubilant Life's Nanjangud facility may face regulatory action by USFDA

 Jubilant Life Sciences on Friday said it has been cautioned by the US health regulator that its Nanjangud facility in Mysore, may be subject to regul
22-03-2019
Next Page
Close

Let's Open Free Demat Account